Overview Since the enactment of Open Payments (Sunshine Act), Life Sciences organizations have faced the daunting task of collecting, verifying, and reporting compliance-related spend and research. The necessary tracking is time-consuming and can be error-prone, leaving exposure to risk. Penalties for knowing failure to submit timely, accurate, or complete information to the Centers for Medicare…
With 2019 reporting to CMS Open Payments (Sunshine Act) now complete, it’s a great time to reflect on how you can improve your current reporting processes for next year. The March 31, 2020 reports presented a number of unique reporting challenges, with CMS rolling out new validation requirements for zip codes, drug names, and National…
Signed into law on October 24, 2018, the ‘Fighting the Opioid Epidemic with Sunshine Act’ expands the scope of reporting requirements under the Open Payments (Sunshine Act) program to include Advanced Practice Registered Nurses (APRN) and Physician Assistants (PA) in the definition of a Covered Recipient. Starting on January 1, 2022, Life Sciences organizations will…
